Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Hypophosphatasia (HPP) is frequently missed or misdiagnosed because its hidden red flags, such as persistently low alkaline phosphatase (ALP) on routine blood work, early loss of baby teeth, recurring stress fractures, chronic bone and muscle pain, and fatigue, are often blamed on osteoporosis, fibromyalgia, arthritis, or vitamin D deficiency instead. Many clinicians overlook a low ALP result since lab reports tend to flag high values, and adult-onset HPP symptoms can appear vague, intermittent, or unrelated to one another. Knowing which patterns warrant repeat ALP testing, vitamin B6 and phosphoethanolamine levels, ALPL gene testing, or a referral to a metabolic bone specialist can shorten a diagnostic delay that often stretches for years. There are several important factors and warning signs to consider, so see below to understand more before assuming a common diagnosis explains everything.
If your symptoms have been dismissed or keep returning without a clear answer, a free, instant, online symptom check can help you organize your history, surface patterns worth flagging, and walk into your next appointment with clearer questions and better direction.
Last reviewed for medical accuracy: 08/18/2026
Hypophosphatasia (HPP) is a rare genetic disorder characterized by low activity of the enzyme alkaline phosphatase (ALP). In adults, HPP often goes unrecognized because its signs overlap with more common conditions and because most clinicians expect ALP levels to be high in bone disease—not low. Understanding the subtle clues and knowing what to do next can help you get the right diagnosis and care.
• Genetic defect in the ALPL gene reduces alkaline phosphatase activity.
• Low ALP impairs bone and tooth mineralization, leading to weak bones, fractures and dental problems.
• Severity ranges from life-threatening in infants to mild or atypical in adults.
In adults, symptoms may appear late and vary widely, making it easy to attribute them to aging, osteoporosis or other musculoskeletal issues.
Expectation of High ALP in Bone Disease
– Most bone disorders (e.g., Paget’s disease, bone metastases) cause elevated ALP.
– Low ALP results often get overlooked or dismissed as lab error.
Overlapping Symptoms
– Chronic bone pain and stress fractures mimic osteoporosis or osteomalacia.
– Muscle aches, fatigue and joint discomfort can suggest fibromyalgia or arthritis.
Misinterpretation of Lab Results
– Single low ALP reading may be attributed to poor nutrition, zinc deficiency or lab variability.
– Lack of follow-up on persistently low ALP.
Rarity and Low Awareness
– Many clinicians see very few HPP cases in their career.
– Rare-disease panels often focus on more common metabolic or rheumatologic disorders.
Misdiagnosis Leads to Inappropriate Treatment
– Bisphosphonates (common osteoporosis drugs) can worsen HPP by further inhibiting bone turnover.
– Pain management alone misses the underlying metabolic defect.
If you’ve been told you have osteoporosis, arthritis or fibromyalgia but treatments aren’t helping—and if routine labs show low ALP—consider these clues:
• Persistently Low Serum ALP
– Two or more readings below the normal range (typically ≤ 40 U/L for adults).
• Unexplained Stress Fractures or Pseudofractures
– Recurrent metatarsal or femoral shaft fractures with minimal trauma.
• Early Adult Tooth Loss
– Premature loss of permanent teeth, especially molars, without gum disease.
• Chronic Musculoskeletal Pain and Fatigue
– Muscle weakness, aches and joint stiffness that don’t respond to standard therapies.
• Family History
– Relatives with similar bone or dental problems, even if they were never diagnosed.
This tool can help you gather information on your symptoms and lab results before your appointment.
Once diagnosed, management focuses on addressing the enzyme deficiency and preventing further complications:
• Enzyme Replacement Therapy (Asfotase Alfa)
– FDA-approved for pediatric-onset HPP, increasingly used off-label in adults.
– Improves bone mineralization, reduces pain and lowers fracture risk.
• Supportive Care
– Orthopedic interventions for fractures and deformities.
– Dental care to manage tooth loss and maintain oral health.
• Pain Management and Physical Therapy
– Tailored exercise programs to strengthen muscles around affected bones.
– Non-pharmacologic pain strategies (heat, massage, low-impact activities).
• Avoid Bisphosphonates
– These drugs inhibit bone turnover and may worsen HPP.
• Bring a printout of your ALP results and any PEA or B6 levels.
• Share your family history, even if relatives were never diagnosed.
• Describe any dental issues in detail (age of tooth loss, gum health).
• Ask directly if HPP could explain your low ALP and symptoms.
• Request referral to a metabolic bone specialist if needed.
Some HPP complications can become serious:
• Signs of infection or non-healing fractures
• Severe muscle weakness limiting mobility
• Uncontrolled pain that impacts daily life
Speak to a doctor right away if you experience any life-threatening or rapidly worsening symptoms.
Hypophosphatasia in adults is often missed because its hallmark—low ALP—runs counter to what most clinicians expect in bone disease. By recognizing the hidden red flags and taking these next steps, you can help your care team arrive at the right diagnosis and treatment plan. Don’t hesitate to:
Early recognition and targeted therapy can improve bone health, reduce pain and enhance quality of life for adults living with HPP.
(References)
* Whyte MP. Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2016 Apr;12(4):233-46. doi: 10.1038/nrendo.2016.14. Epub 2016 Feb 19. PMID: 26893260.
* Linglart A, Biosse-Duplan M. Hypophosphatasia. Curr Osteoporos Rep. 2016 Jun;14(3):95-105. doi: 10.1007/s11914-016-0309-0. PMID: 27084188.
* Mornet E. Hypophosphatasia. Metabolism. 2018 May;82:142-155. doi: 10.1016/j.metabol.2017.08.013. Epub 2017 Sep 20. PMID: 28939177.
* Briot K, Roux C. Adult hypophosphatasia. Arch Pediatr. 2017 May;24(5S2):5S71-5S73. doi: 10.1016/S0929-693X(18)30018-6. PMID: 29405936.
* Fenn JS, Lorde N, Ward JM, Borovickova I. Hypophosphatasia. J Clin Pathol. 2021 Oct;74(10):635-640. doi: 10.1136/jclinpath-2021-207426. Epub 2021 Apr 30. PMID: 33931563.
* Riancho JA. Diagnostic Approach to Patients with Low Serum Alkaline Phosphatase. Calcif Tissue Int. 2023 Mar;112(3):289-296. doi: 10.1007/s00223-022-01039-y. Epub 2022 Nov 8. PMID: 36348061.
* Brandi ML, Khan AA, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Lewiecki EM, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Roux C. The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance. Osteoporos Int. 2024 Mar;35(3):439-449. doi: 10.1007/s00198-023-06859-8. Epub 2023 Nov 20. PMID: 37982856.
* Khan AA, Brandi ML, Rush ET, Ali DS, Al-Alwani H, Almonaei K, Alsarraf F, Bacrot S, Dahir KM, Dandurand K, Deal C, Ferrari SL, Giusti F, Guyatt G, Hatcher E, Ing SW, Javaid MK, Khan S, Kocijan R, Linglart A, M'Hiri I, Marini F, Nunes ME, Rockman-Greenberg C, Roux C, Seefried L, Simmons JH, Starling SR, Ward LM, Yao L, Brignardello-Petersen R, Lewiecki EM. Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults. Osteoporos Int. 2024 Mar;35(3):431-438. doi: 10.1007/s00198-023-06844-1. Epub 2023 Nov 20. PMID: 37982857; PMCID: PMC10866785.
* Seefried L, Genest F, Hofmann C, Brandi ML, Rush E. Diagnosis and Treatment of Hypophosphatasia. Calcif Tissue Int. 2025 Mar 6;116(1):46. doi: 10.1007/s00223-025-01356-y. Epub 2025 Mar 6. PMID: 40047955; PMCID: PMC11885340.
* Reicher L, Shilo S, Godneva A, Lutsker G, Zahavi L, Shoer S, Krongauz D, Rein M, Kohn S, Segev T, Schlesinger Y, Barak D, Levine Z, Keshet A, Shaulitch R, Lotan-Pompan M, Elkan M, Talmor-Barkan Y, Aviv Y, Dadiani M, Tsodyks Y, Gal-Yam EN, Leibovitzh H, Werner L, Tzadok R, Maharshak N, Koga S, Glick-Gorman Y, Stossel C, Raitses-Gurevich M, Golan T, Dhir R, Reisner Y, Weinberger A, Rossman H, Song L, Xing EP, Segal E. Deep phenotyping of health-disease continuum in the Human Phenotype Project. Nat Med. 2025 Sep;31(9):3191-3203. doi: 10.1038/s41591-025-03790-9. Epub 2025 Jul 15. PMID: 40665053.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.